Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.36B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$236M |
| 3 |
Apple
AAPL
|
+$223M |
| 4 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$222M |
| 5 |
Southern Company
SO
|
+$182M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FON
SPRINT CORP FON COM
FON
|
+$724M |
| 2 |
Pfizer
PFE
|
+$469M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$409M |
| 4 |
iShares US Real Estate ETF
IYR
|
+$407M |
| 5 |
Zoetis
ZTS
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.63% |
| 2 | Healthcare | 4.25% |
| 3 | Technology | 4.18% |
| 4 | Energy | 3.42% |
| 5 | Communication Services | 3.3% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3926
Minerals Technologies
MTX
$2.34B
| $554K | ﹤0.01% |
11,300
-2,496
| -18% | -$115K |
|
3927
PUT
Perrigo
PRGO
$1.78B
| $554K | ﹤0.01% |
4,500
-43,000
| -91% | -$5.37M |
|
3928
Spok Holdings
SPOK
$241M
| $554K | ﹤0.01% |
39,532
+7,179
| +22% | +$103K |
|
3929
Calumet Specialty Products
CLMT
$3.44B
| $553K | ﹤0.01% |
20,477
+2,136
| +12% | +$67.1K |
|
3930
Geospace Technologies
GEOS
$75.7M
| $553K | ﹤0.01% |
6,589
-5,111
| -44% | -$381K |
|
|
GES
3931
CALL
DELISTED
Guess Inc
GES
| $551K | ﹤0.01% |
19,000
-1,500
| -7% | -$46.9K |
|
3932
CALL
Invesco Mortgage Capital
IVR
$805M
| $550K | ﹤0.01% |
3,660
+1,600
| +78% | +$253K |
|
|
HK
3933
CALL
DELISTED
Halcon Resources Corporation
HK
| $550K | ﹤0.01% |
798
+396
| +99% | +$361K |
|
3934
PUT
Bread Financial
BFH
$4.38B
| $549K | ﹤0.01% |
3,258
-5,388
| -62% | -$854K |
|
3935
PUT
Raymond James Financial
RJF
$34B
| $549K | ﹤0.01% |
20,100
+1,050
| +6% | +$30.3K |
|
|
AUXL
3936
CALL
DELISTED
AUXILIUM PHARAMCEUTICALS INC
AUXL
| $549K | ﹤0.01% |
30,500
-24,200
| -44% | -$437K |
|
3937
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.9B
| $547K | ﹤0.01% |
6,077
+3,616
| +147% | +$331K |
|
3938
Bio-Rad Laboratories Class A
BIO
$9.42B
| $547K | ﹤0.01% |
4,672
+1,725
| +59% | +$203K |
|
3939
HSBC
HSBC
$356B
| $547K | ﹤0.01% |
11,780
-79,452
| -87% | -$3.77M |
|
|
JKS
3940
PUT
JinkoSolar
JKS
$891M
| $546K | ﹤0.01% |
24,800
+3,700
| +18% | +$54.9K |
|
3941
CALL
United Therapeutics
UTHR
$23.1B
| $546K | ﹤0.01% |
7,000
-59,700
| -90% | -$4.36M |
|
3942
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$228M
| – | – |
0
| – | – |
|
3943
John Wiley & Sons Class A
WLY
$2.66B
| $546K | ﹤0.01% |
11,613
+2,523
| +28% | +$113K |
|
|
MDC
3944
CALL
DELISTED
M.D.C. Holdings, Inc.
MDC
| $546K | ﹤0.01% |
25,277
+14,444
| +133% | +$318K |
|
|
MCF
3945
DELISTED
Contango Oil & Gas Co.
MCF
| $546K | ﹤0.01% |
15,182
+19
| +0.1% | +$716 |
|
|
SOL
3946
CALL
DELISTED
Emeren Group
SOL
| $545K | ﹤0.01% |
27,240
+26,720
| +5,138% | +$548K |
|
|
AWAY
3947
DELISTED
HOMEAWAY INC COM
AWAY
| $545K | ﹤0.01% |
20,212
+5,731
| +40% | +$178K |
|
3948
PUT
Steel Dynamics
STLD
$37.6B
| $544K | ﹤0.01% |
34,000
-4,500
| -12% | -$71.4K |
|
3949
Resources Connection
RGP
$145M
| $543K | ﹤0.01% |
41,775
-623
| -1% | -$8.16K |
|
|
TBI
3950
Trueblue
TBI
$311M
| $543K | ﹤0.01% |
22,606
-10,481
| -32% | -$262K |
|
Similar funds
Barclays's Q3 2013 Portfolio in Review
As of Q3 2013, Barclays held 8,017 positions worth $83.8B, up 4.2% from $80.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays's Q3 2013 filing shows 302 new, 3,328 increased, 3,470 reduced and 580 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M. The largest sale was SPRINT CORP FON COM, an estimated $724M.
By sector, the portfolio is most concentrated in Financials at 4.6% of assets, up from 4.5% a quarter earlier, followed by Healthcare and Technology.
- Barclays's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 2,167,568 shares worth $71.5M.
- Barclays added most to iPath ETNs Linked to the MSCI India Total Return Index in Q3 2013, an estimated $1.36B increase.
- Barclays's biggest Q3 2013 reduction was Pfizer, cutting an estimated $469M.
- Barclays fully exited SPRINT CORP FON COM in Q3 2013, selling an estimated $724M.
- Barclays's ten largest holdings make up 26% of its $83.8B portfolio in Q3 2013.
- Barclays opened 302 new positions and closed 580 in Q3 2013.
- Barclays's portfolio value rose 4.2% quarter-over-quarter to $83.8B.
Based on Barclays's 13F filing for Q3 2013, filed 14 Nov 2013.